News ArchivesRead News

Chemicals in Cigarette Smoke, Auto Exhaust and French Fries Accelerate the Development of Alzheimer's Disease

Wednesday November 17, 2010

PR Newswire - There is growing evidence that exposure to a group of chemicals known as type-2 alkenes -- which are found in the smoke inhaled from cigarettes, the exhaust of automobiles and even in French fries – can increase the chances of developing Alzheimer's disease and other neurological conditions such as Parkinson's disease.

"The thought process and memory deficits associated with Alzheimer's disease appear to be due to the very early loss of function of nerve endings in the brain," said Richard M. LoPachin, Ph.D., a neurochemist and director of research in the Department of Anesthesiology at Montefiore Medical Center and the Albert Einstein College of Medicine.

"Two years ago, we published a series of peer-review papers describing how type-2 alkenes (such as acrylamide and acrolein) damage nerve endings in the brains of animals and, since then, interest in the scientific community has grown steadily," said Dr. LoPachin.

"For example, just in the last six months there were more than a half dozen articles published in neuroscience journals that demonstrate an excess of acrolein and other type-2 alkenes in the brains of Alzheimer's patients."

The Perfect Neurological Storm

According to Dr. LoPachin, this excess means that these highly toxic chemicals are also being generated within nerve endings during the disease process that presumably initiates Alzheimer's dementia. Dr. LoPachin believes that this internal production of the type-2 alkenes, along with external exposure to these chemicals (smoking, diet and other environmental factors), causes a perfect neurological storm – a doubly powerful type-2 alkene attack on brain nerve endings from outside the body and from within.

"This dual intoxication of nerve endings led us to conclude that daily environmental exposure to neurotoxic type-2 alkenes could increase the incidence of Alzheimer's disease," he said.

Can Curry, Wine and Apple Skins Offer a Cure?

As evidence for the role of type-2 alkenes in neurological disorders such as Alzheimer's disease has grown, Dr. LoPachin and his colleague, Dr. Terrence Gavin, in the Department of Chemistry at Iona College, have discovered a possible antidote that is derived from chemical compounds found in curry spice (curcumin), wine (resveratrol) and apple skins (phloretin).

Their research, recently reported in a Journal of Neurochemistry article (Title: B-Dicarbonyl Enolates: A New Class of Neuroprotectants), showed that a compound called 2-ACP completely protected nerve cells in culture from acrolein-induced damage by latching onto this type-2 alkene and neutralizing its toxic effects. 2-ACP could, therefore, be a treatment for neurological conditions such as Alzheimer's and Parkinson's disease. Drs. LoPachin and Gavin believe that 2-ACP treatment would be safe and effective in humans, because it is derived from non-toxic natural products that already have clinically demonstrated neuroprotective properties.

Dr. LoPachin says that although the 2-ACP studies are quite advanced in the world of molecular biology, they nonetheless will need to be confirmed in animal studies.

Recent News

Oct 2 - A New Attack on Parkinson's Disease
Oct 2 - Antipsychotics for Parkinson's Psychosis May Be Dangerous
Sep 27 - The beginning of the end? The race for a Parkinson’s cure
Sep 23 - Scientists map Parkinson's spread in brain
Sep 22 - Understanding Parkinson's Disease: An Interview with Jon Palfreman
Sep 22 - Living with Lewy Body Dementia
Sep 21 - Adults with autism likely to develop Parkinson’s disease, says study
Sep 16 - Everyday activity more beneficial than occasional strenuous exercise for Parkinson’s disease
Sep 14 - UNC scientists create smarter immune cells to treat Parkinson's disease
Sep 9 - A newly discovered brain disease may point to something disturbing about Alzheimer’s and Parkinson’s
Sep 7 - Treatment for Parkinson's could replace surgery
Sep 4 - Asthma May Influence Risk of Parkinson's Disease
Sep 4 - Researchers Explore Memory Problems Related to Parkinson's
Sep 3 - Press Release: ACADIA Pharmaceuticals Submits New Drug Application for NUPLAZID™ for the Treatment of Parkinson’s Disease Psychosis
Aug 28 - Brain cells 'burn out' in Parkinson's disease
Aug 24 - Study Details Process Involved in Parkinson’s Disease
Aug 24 - Google Reveals Gigantic Ambitions To Fight Cancer, Diabetes, Parkinson's, Heart Problems
Aug 20 - Two proteins work together to help cells eliminate trash; Parkinson's may result
Aug 17 - Scientists visualize critical part of basal ganglia pathways
Aug 17 - VA benefits office seeks all vets exposed to Agent Orange